Foreign-Trade Zone (FTZ) 76-Danbury, Connecticut Notification of Proposed Production Activity; MannKind Corporation, (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut, 1689 [2016-32034]
Download as PDF
Federal Register / Vol. 82, No. 4 / Friday, January 6, 2017 / Notices
II. Basis for CAPS Expansion
DEPARTMENT OF COMMERCE
A. Purpose
Foreign-Trade Zones Board
CAPS is designed to provide
managers at the lowest organizational
level the authority, control, and
flexibility to recruit, retain, develop,
recognize, and motivate its workforce,
while ensuring adequate accountability
and oversight.
The ESO is a new organization
designed to deliver common business
support and mission-enabling services
in the functional areas of human
resources, acquisition, information
technology financial management, and
other areas as determined necessary.
The mission of the ESO is to: Enhance
customer experience through the
efficient delivery of high-quality
mission-enabling services; increase
service transparency and accountability;
and enable employees, currently
performing these functions, to dedicate
more time to the unique mission needs
of their organization. The expansion of
CAPS coverage to include the ESO,
should improve the organization’s
ability to recruit and retain a highquality workforce to meet the
organization’s mission.
DoC’s CAPS allows for modifications
of procedures if no new waiver from law
or regulation is added. Given that this
expansion and modification is in
accordance with existing law and
regulation and CAPS is a permanent
alternative personnel system, the DoC is
authorized to make the changes
described in this notice.
B. Participating Employees
Employee notification of this
expansion will be accomplished by
providing employees and managers
electronic access to all CAPS policies
and procedures, including the eleven
previous Federal Register Notices. A
copy of this Federal Register notice will
also be accessible electronically upon
approval. Supervisor training and
informational briefings for employees
will be conducted as the ESO undergoes
full transition over a period of a few
years.
sradovich on DSK3GMQ082PROD with NOTICES
III. Changes to the Project Plan
The CAPS at DoC, published in the
Federal Register on December 24, 1997
(62 FR 67434), is amended as follows:
1. The following organization will be
added to the project plan, Section II D—
Participating Organizations
Office of the Secretary (OS), Office of
the Deputy Secretary, Enterprise
Services Organization (ESO)
[FR Doc. 2017–00057 Filed 1–5–17; 8:45 am]
BILLING CODE 3510–EA–P
VerDate Sep<11>2014
18:06 Jan 05, 2017
Jkt 241001
[B–085–2016]
Foreign-Trade Zone (FTZ) 76—
Danbury, Connecticut Notification of
Proposed Production Activity;
MannKind Corporation, (Fumaryl
Diketopiperazone (FDKP) Carrier/
Receptor Powder), Danbury,
Connecticut
MannKind Corporation (MannKind)
submitted a notification of proposed
production activity to the FTZ Board for
its facility in Danbury, Connecticut
within Subzone 76B. The notification
conforming to the requirements of the
regulations of the FTZ Board (15 CFR
400.22) was received on December 21,
2016.
MannKind currently has authority to
use the facility for the production of
Technosphere Insulin®, an inhalable
insulin made by a combination of
imported fumaryl diketopiperazone
(FDKP) and domestic material active
ingredients. MannKind’s current request
would add a finished product to the
scope of authority. Pursuant to 15 CFR
400.14(b), FTZ activity would be limited
to the specific foreign-status materials
and components and specific finished
products described in the submitted
notification (as described below) and
subsequently authorized by the FTZ
Board.
Production under FTZ procedures
could exempt MannKind from customs
duty payments on the foreign-status
components used in export production.
On its domestic sales, MannKind would
be able to choose the duty rate during
customs entry procedures that applies to
FDKP carrier/receptor powder (duty rate
6.5%) for the foreign-status components
and materials in the existing scope of
authority. Customs duties also could
possibly be deferred or reduced on
foreign-status production equipment.
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary at the address below. The
closing period for their receipt is
February 15, 2017.
A copy of the notification will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room
21013, U.S. Department of Commerce,
1401 Constitution Avenue NW.,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the Board’s
Web site, which is accessible via
www.trade.gov/ftz.
PO 00000
Frm 00005
Fmt 4703
Sfmt 4703
1689
For further information, contact
Juanita H. Chen at Juanita.Chen@
trade.gov or (202) 482–1378.
Dated: December 28, 2016.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2016–32034 Filed 1–5–17; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
In the Matter of: Dane Francisco
Delgado, Inmate Number: 60114–379,
Eden, Correctional Institution, P.O.
Box 605, Eden, TX 76837; Order
Denying Export Privileges
On November 4, 2014, in the U.S.
District Court for the Southern District
of Texas, Dane Francisco Delgado
(‘‘Delgado’’), was convicted of violating
Section 38 of the Arms Export Control
Act (22 U.S.C. 2778 (2012)) (‘‘AECA’’).
Specifically, Delgado knowingly and
willfully conspired with persons known
and unknown to export, furnish, and
cause to be exported from the United
States to Mexico defense articles
designated on the United States
Munitions List without having first
obtained from the Department of State a
license or written authorization for such
export. Delgado was sentenced to 60
months in prison, three years of
supervised release, and a $100
assessment.
Section 766.25 of the Export
Administration Regulations (‘‘EAR’’ or
‘‘Regulations’’) 1 provides, in pertinent
part, that ‘‘[t]he Director of the Office of
Exporter Services, in consultation with
the Director of the Office of Export
Enforcement, may deny the export
privileges of any person who has been
convicted of a violation of the Export
Administration Act (‘‘EAA’’), the EAR,
or any order, license or authorization
issued thereunder; any regulation,
license, or order issued under the
International Emergency Economic
Powers Act (50 U.S.C. 1701–1706); 18
U.S.C. 793, 794 or 798; section 4(b) of
the Internal Security Act of 1950 (50
1 The Regulations are currently codified in the
Code of Federal Regulations at 15 CFR parts 730–
774 (2016). The Regulations issued pursuant to the
Export Administration Act (50 U.S.C. 4601–4623
(Supp. III 2015) (available at https://
uscode.house.gov)). Since August 21, 2001, the Act
has been in lapse and the President, through
Executive Order 13222 of August 17, 2001 (3 CFR,
2001 Comp. 783 (2002)), which has been extended
by successive Presidential Notices, the most recent
being that of August 4, 2016 (81 FR 52587 (Aug. 8,
2016)), has continued the Regulations in effect
under the International Emergency Economic
Powers Act (50 U.S.C. 1701, et seq. (2006 & Supp.
IV 2010)).
E:\FR\FM\06JAN1.SGM
06JAN1
Agencies
[Federal Register Volume 82, Number 4 (Friday, January 6, 2017)]
[Notices]
[Page 1689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-32034]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-085-2016]
Foreign-Trade Zone (FTZ) 76--Danbury, Connecticut Notification of
Proposed Production Activity; MannKind Corporation, (Fumaryl
Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut
MannKind Corporation (MannKind) submitted a notification of
proposed production activity to the FTZ Board for its facility in
Danbury, Connecticut within Subzone 76B. The notification conforming to
the requirements of the regulations of the FTZ Board (15 CFR 400.22)
was received on December 21, 2016.
MannKind currently has authority to use the facility for the
production of Technosphere Insulin[supreg], an inhalable insulin made
by a combination of imported fumaryl diketopiperazone (FDKP) and
domestic material active ingredients. MannKind's current request would
add a finished product to the scope of authority. Pursuant to 15 CFR
400.14(b), FTZ activity would be limited to the specific foreign-status
materials and components and specific finished products described in
the submitted notification (as described below) and subsequently
authorized by the FTZ Board.
Production under FTZ procedures could exempt MannKind from customs
duty payments on the foreign-status components used in export
production. On its domestic sales, MannKind would be able to choose the
duty rate during customs entry procedures that applies to FDKP carrier/
receptor powder (duty rate 6.5%) for the foreign-status components and
materials in the existing scope of authority. Customs duties also could
possibly be deferred or reduced on foreign-status production equipment.
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary at the address
below. The closing period for their receipt is February 15, 2017.
A copy of the notification will be available for public inspection
at the Office of the Executive Secretary, Foreign-Trade Zones Board,
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW.,
Washington, DC 20230-0002, and in the ``Reading Room'' section of the
Board's Web site, which is accessible via www.trade.gov/ftz.
For further information, contact Juanita H. Chen at
Juanita.Chen@trade.gov or (202) 482-1378.
Dated: December 28, 2016.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2016-32034 Filed 1-5-17; 8:45 am]
BILLING CODE 3510-DS-P